CORD-19:dc97e1de3b69da13f534f15afdcedbf48064c69d / 701324-701445 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T5581","span":{"begin":0,"end":121},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Long-term therapy with low-molecular-weight heparin or warfarin may be required to prevent further thromboembolic events."}

{"project":"Epistemic_Statements","denotations":[{"id":"T2239","span":{"begin":0,"end":121},"obj":"Epistemic_statement"}],"text":"Long-term therapy with low-molecular-weight heparin or warfarin may be required to prevent further thromboembolic events."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T61","span":{"begin":0,"end":121},"obj":"Sentence"}],"text":"Long-term therapy with low-molecular-weight heparin or warfarin may be required to prevent further thromboembolic events."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T3613","span":{"begin":99,"end":120},"obj":"Phenotype"}],"attributes":[{"id":"A3613","pred":"hp_id","subj":"T3613","obj":"http://purl.obolibrary.org/obo/HP_0001907"}],"text":"Long-term therapy with low-molecular-weight heparin or warfarin may be required to prevent further thromboembolic events."}